Haritaki and Cancer Research: Why Are Scientists Testing It on Cancer Cells?

Haritaki Has Actually Been Put on Cancer Cells

Haritaki (Terminalia chebula) is an ancient Ayurvedic fruit—but some modern research surrounding it looks surprisingly different from traditional herbal medicine.

Scientists have taken extracts and individual compounds from Haritaki and tested them directly against breast, prostate, colon, lung, leukemia and other cancer cell lines in laboratories.

So what happened?

Researchers Saw Cancer Cell Growth Slow Down

One study published in the Journal of Ethnopharmacology tested Terminalia chebula fruit extract against several cultured cancer cell lines, including human breast cancer, prostate cancer and osteosarcoma cells.

Researchers reported reduced cell proliferation and viability, with increasing concentrations producing greater effects. They also observed forms of cell death. PubMed

More than two decades later, scientists are still investigating the same botanical.

A 2023 study exposed MCF-7 human breast cancer cells to Haritaki fruit extract and reported reduced proliferation and dose-dependent apoptosis—the biological process often described as programmed cell death. PubMed

One Haritaki Compound Is Especially Interesting

Haritaki isn't a single chemical.

Its fruit contains numerous compounds, including chebulagic acid and chebulinic acid.

Researchers isolated chebulagic acid from Terminalia chebula and tested it against several cancer cell lines. In laboratory experiments, the compound showed antiproliferative activity and induced apoptosis in COLO-205 colon cancer cells. PubMed

Chebulinic acid has attracted attention too.

A 2017 laboratory study reported that chebulinic acid induced apoptosis in certain acute myeloid leukemia cell lines, with researchers investigating caspases and other molecular pathways involved in the process. PubMed

What About Lung and Breast Cancer?

Another laboratory study tested Haritaki fruit extract against A549 lung cancer cells and MCF-7 breast cancer cells.

Researchers reported cytotoxic and apoptotic effects and observed changes involving the Bax/Bcl-2 and caspase pathways—molecular systems involved in regulating cell survival and death. PubMed

More recently, researchers have even investigated Terminalia chebula fractions in oral squamous cell carcinoma cells, including experiments combining one fraction with the chemotherapy drug cisplatin. Again, this was laboratory cell research—not evidence of a cancer treatment in people. PubMed

Does This Mean Haritaki Treats Cancer?

No. And this distinction is crucial.

Killing or slowing cancer cells in a laboratory is very different from safely and effectively treating cancer in the human body.

These experiments do not demonstrate that Haritaki capsules prevent, cure or treat cancer. They also don't show that taking Haritaki reproduces the concentrations or biological effects researchers create in laboratory experiments.

Cancer treatment should never be replaced or delayed because of these findings.

So Why Is the Research Interesting?

Because scientists aren't simply repeating ancient claims.

They're isolating Haritaki compounds, placing them into controlled experiments and examining what happens to cell proliferation, apoptosis and molecular signaling pathways.

Most of those questions remain far from answered.

But for a fruit used for centuries in traditional medicine, the fact that Terminalia chebula continues appearing in modern cancer laboratories is a fascinating part of the Haritaki story.

Curious about the ancient botanical behind the research? Explore Harlowi Haritaki Third Eye Capsules below.